Cozad Asset Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-187
| Closed | -$23K | – | 351 |
|
|
2022
Q2 | $23K | Hold |
187
| – | – | ﹤0.01% | 347 |
|
|
2022
Q1 | $39K | Hold |
187
| – | – | 0.01% | 350 |
|
|
2021
Q4 | $37K | Buy |
187
+17
| +10% | +$3.36K | 0.01% | 351 |
|
|
2021
Q3 | $47K | Buy |
170
+67
| +65% | +$18.5K | 0.01% | 346 |
|
|
2021
Q2 | $37K | Buy |
103
+66
| +178% | +$23.7K | 0.01% | 347 |
|
|
2021
Q1 | $18K | Hold |
37
| – | – | ﹤0.01% | 350 |
|
|
2020
Q4 | $23K | Buy |
+37
| New | +$23K | ﹤0.01% | 327 |
|